Literature DB >> 28869267

Multimodal imaging and photothermal therapy were simultaneously achieved in the core-shell UCNR structure by using single near-infrared light.

Chen Wang1, Liangge Xu2, Jiating Xu2, Dan Yang2, Bin Liu2, Shili Gai2, Fei He2, Piaoping Yang2.   

Abstract

Core-shell nanostructures consisting of plasmonic materials and lanthanide-doped upconversion nanoparticles (UCNPs) show promising applications in theranostics including bio-imaging, diagnosis and therapy. However, some challenges still remain in the synthetic control because of the non-coordination between energy transfer and photothermal therapy (PTT). Herein, we developed a novel type of thermal-fluorescent core-shell hybrid nanocomposite incorporating rare-earth Yb3+ and Er3+ ion doped GdOF as the shell and gold nanorods (GNRs) as the core, creating upconversion nanorods (UCNRs) of GNRs@GdOF:Yb3+,Er3+. In order to facilitate the absorption or excretion of UCNRs in vivo, we designed gold nanorods with lower aspect ratios by reducing the amount of CTAB in the growth solution. More importantly, under 980 nm near-infrared (NIR) light irradiation, the green and red emissions of GdOF:Yb3+,Er3+ generally overlap with the visible absorbance of GNRs; by altering the contents of Yb3+ and Er3+ ions appropriately, the localized surface plasmon resonance (LSPR) absorption of low aspect ratio GNRs under 980 nm NIR laser excitation can be enhanced for improving the PTT efficiency. Furthermore, in vitro and in vivo assays reveal that the composite has excellent bio-compatibility and cancer therapy efficiency. This multi-functional nanocomposite, which possesses upconversion luminescence and photothermal and biocompatibility properties, shows strong potential for application in bio-imaging and photothermal anti-cancer therapy.

Entities:  

Year:  2017        PMID: 28869267     DOI: 10.1039/c7dt02791e

Source DB:  PubMed          Journal:  Dalton Trans        ISSN: 1477-9226            Impact factor:   4.390


  2 in total

1.  Unveiling the effect of 11-MUA coating on biocompatibility and catalytic activity of a gold-core cerium oxide-shell-based nanozyme.

Authors:  Vidhi Jain; Stuti Bhagat; Mandeep Singh; Vipul Bansal; Sanjay Singh
Journal:  RSC Adv       Date:  2019-10-16       Impact factor: 4.036

2.  Theranostic nanobubble encapsulating a plasmon-enhanced upconversion hybrid nanosystem for cancer therapy.

Authors:  Wen-Tse Huang; Ming-Hsien Chan; Xueyuan Chen; Michael Hsiao; Ru-Shi Liu
Journal:  Theranostics       Date:  2020-01-01       Impact factor: 11.556

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.